ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01629667
Brief Title: A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis

First Submitted : June 12, 2012
First Submitted that Met QC Criteria : June 26, 2012
First Posted : June 27, 2012 (Estimate)

Results First Submitted : January 19, 2017
Results First Submitted that Met QC Criteria : April 28, 2017
Results First Posted : May 15, 2017

Last Update Submitted that Met QC Criteria : April 28, 2017
Last Update Posted : May 15, 2017